Literature DB >> 1680737

Focal stimulation of specific pathways in the rat hippocampus causes a reduction in radioligand binding to the haloperidol-sensitive sigma receptor.

M A Connor1, C Chavkin.   

Abstract

Focal electrical stimulation of selected excitatory pathways in the hippocampal slice caused a decrease in the binding of [3H]-1,3-di(2-tolyl)guanidine (DTG) or [3H]-(+)-3-[hydroxyphenyl]-N-(1-propyl)piperidine [( 3H )-(+)3-PPP) to haloperidol-sensitive sigma binding sites in the slice. Activation of the mossy fibers or perforant path by high frequency electrical stimulation caused the reduction in [3H]-DTG binding; whereas activation of fibers in the strata radiatum, lacunosum-moleculare, alveus, or oriens did not affect [3H]-DTG binding. The decrease in binding observed was calcium-dependent and tetrodotoxin sensitive and varied with the frequency, intensity, and duration of stimulation. Although haloperidol-sensitive [3H]-DTG binding sites are distributed throughout the hippocampus, stimulation of the perforant path or mossy fibers resulted in a significant reduction in binding only in the dentate region of the slice. The decrease in binding following perforant path stimulation was blocked by the glutamate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX); whereas the decrease in binding caused by mossy fiber stimulation was not affected by CNQX or DL-APV. The results obtained support the hypothesis that activation of the granule cells in the hippocampal slice caused the release of an endogenous ligand which acts at the haloperidol-sensitive sigma binding site in the dentate gyrus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680737     DOI: 10.1007/bf00231736

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  34 in total

1.  Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat.

Authors:  A M Graybiel; M J Besson; E Weber
Journal:  J Neurosci       Date:  1989-01       Impact factor: 6.167

2.  BW 234U, (cis-9-[3-(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agent.

Authors:  R M Ferris; M Harfenist; G M McKenzie; B Cooper; F E Soroko; R A Maxwell
Journal:  J Pharm Pharmacol       Date:  1982-06       Impact factor: 3.765

Review 3.  Excitatory amino acid transmitters.

Authors:  J C Watkins; R H Evans
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

4.  Peptidergic transmission in sympathetic ganglia of the frog.

Authors:  L Y Jan; Y N Jan
Journal:  J Physiol       Date:  1982-06       Impact factor: 5.182

5.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

6.  Efflux of rubidium in rat cortical synaptosomes is blocked by sigma and dextromethorphan binding site ligands.

Authors:  E J Fletcher; C Drew; D Lodge; C T O'Shaughnessy
Journal:  Neuropharmacology       Date:  1989-07       Impact factor: 5.250

7.  An examination of the putative sigma-receptor in the mouse isolated vas deferens.

Authors:  C Kennedy; G Henderson
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

8.  Cerebral metabolic effects of sigma ligands in the rat.

Authors:  A della Puppa; E D London
Journal:  Brain Res       Date:  1989-12-29       Impact factor: 3.252

9.  New quinoxalinediones show potent antagonism of quisqualate responses in cultured mouse cortical neurons.

Authors:  J Drejer; T Honoré
Journal:  Neurosci Lett       Date:  1988-04-22       Impact factor: 3.046

10.  Stimulation of endogenous opioid release displaces mu receptor binding in rat hippocampus.

Authors:  J J Wagner; R M Caudle; J F Neumaier; C Chavkin
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

View more
  2 in total

1.  Targeting sigma receptors: novel medication development for drug abuse and addiction.

Authors:  Rae R Matsumoto
Journal:  Expert Rev Clin Pharmacol       Date:  2009-07       Impact factor: 5.045

Review 2.  Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.

Authors:  G Debonnel
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.